Genetic alterations, such as BRAF, RAS, PIK3CA, and PTEN mutations, serve as the driving force behind the activation of the MAPK and PI3K/Akt pathways, which represent the fundamental mechanism in the development of thyroid cancer. This evidence concerns the gene BRAF and thyroid cancer.